Track topics on Twitter Track topics that are important to you
If approved, emicizumab could threaten both Shire and Novo Nordisk's respective hemophilia businesses.
Original Article: Roche lines up February decision date for hemophilia prospectNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...